Clinical Trial

A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Trial Details
NCT Number NCT07436221
Lead Sponsor Akeso
Conditions Asthma
Enrollment 160 participants
Start Date 2026-02-28
Primary Completion 2026-12-27 (estimated)
Study Completion 2027-02-26 (estimated)
Updated on ClinicalTrials.gov 2026-02-27